In mild cases and controlled underlying disease, a “treat through” approach includes the continuation of the TNF inhibitor along with additional psoriasis treatments, such as topical corticosteroids, ultraviolet light therapy, and cyclosporine [7]. This evidence concerns the gene TNF and psoriasis.